ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)
$29.56 -1.01 (-3.3039%)
Analysed ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) News Sources
Acadia Gets European Commission Nod for Daybu in Rett Syndrome
24-08-2026
yahoo.com
Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results
04-08-2026
yahoo.com
ACADIA Pharmaceuticals Inc (ACAD) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...
05-08-2026
yahoo.com
ACAD Q2 Earnings and Revenues Beat, '26 View Raised on Product Sales
05-08-2026
yahoo.com
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
06-08-2026
yahoo.com
Is ACADIA Pharmaceuticals (ACAD) Outperforming Other Medical Stocks This Year?
07-08-2026
yahoo.com
Acadia Pharmaceuticals (ACAD) Stock Gets Fair Value Bump As Analysts Back Daybue Growth
07-08-2026
yahoo.com
Acadia Pharmaceuticals to Gain From Daybue, Nuplazid Growth; RADIANT Data Adds Risk, Morgan Stanley Says
10-08-2026
yahoo.com
Acadia Pharmaceuticals (ACAD) Q2 2026 Earnings Call Transcript
12-08-2026
fool.com
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union
24-08-2026
yahoo.com
What is the current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is $29.56.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is $-1.01.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is -3.3039%.
What is the most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is .
SEC-8K** Filing Available For ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.